United States · Venture startup

Who invested in INNOVUS PHARMACEUTICALS

3 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 15 Nov 2026

$5.1Mraised across 3 rounds since 2013, from 3 sources

$450KSeed$135KSeed$4.5MVenture
Latest round
Seed, $135KAug 2013
Biggest round
$4.5MVenture · Aug 2013
Investors
0
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2014
$450KSeed$135KSeed$4.5MVenture
First round
Seed, $450K
May 2013
Biggest round
$4.5M
Venture · Aug 2013
Between rounds
3 months
from the last two

The rounds

  1. Aug 2013
    Seed$135K

    No investor was named in the report.

    Reported by sec.govSEC filing: $135K sold, first sale Jun 2013

  2. Aug 2013
    Venture$4.5M

    No investor was named in the report.

    Reported by sec.govSEC filing: $135K sold, first sale Jun 2013

  3. May 2013
    Seed$450K

    No investor was named in the report.

    Reported by sec.govSEC filing: $450K sold, first sale Apr 2013

Funding filed with regulators

INNOVUS PHARMACEUTICALS filed 14 raises, $15M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Jan 2019$3.2M1 investorequity, options, securities on exerciseSEC Form D
  2. Jul 2017$145K1 investorequitySEC Form D
  3. Jun 2016$3.0M9 investorsdebt, optionsSEC Form D
  4. Aug 2015$500Kequity, options, securities on exerciseof $1.5M offeredSEC Form D
  5. Feb 2014$742K6 investorsequitySEC Form D
  6. Feb 2014$330K1 investordebt, options, securities on exerciseSEC Form D
  7. Dec 2013$350K1 investordebtSEC Form D
  8. Jun 2013$135K2 investorsequitySEC Form D
  9. May 2013$50K1 investordebt, optionsSEC Form D
  10. Apr 2013$450K1 investorequitySEC Form D
  11. Feb 2013$4.5M6 investorsequity, options, securities on exerciseof $6.0M offeredSEC Form D
  12. Jan 2013$1.1M2 investorsdebt, optionsSEC Form D
  13. Jan 2012$175K6 investorsdebt, optionsSEC Form D
  14. Dec 2011$50K1 investordebt, optionsSEC Form D

Founders and team

From the SEC filings it signed: 3 on the team.

  • Bassam DamajExecutive Officer, Directori
  • Randy BerholtzExecutive Officeri
  • Ryan SelhornExecutive Officeri

On the board, as filediDean NuhailyHenry EsberVivian LiuZiad Mirza

Quick answers about INNOVUS PHARMACEUTICALS

How much has INNOVUS PHARMACEUTICALS raised?

INNOVUS PHARMACEUTICALS has raised $5.1M across 3 rounds since 2013.

When did INNOVUS PHARMACEUTICALS last raise?

INNOVUS PHARMACEUTICALS's most recent round was a Venture of $4.5M in Aug 2013.

What was INNOVUS PHARMACEUTICALS's biggest round?

Its most recent round, $4.5M in Aug 2013, is also its largest on record.

What stage is INNOVUS PHARMACEUTICALS at?

INNOVUS PHARMACEUTICALS's latest named round is a Venture, in Aug 2013.

Where is INNOVUS PHARMACEUTICALS based?

INNOVUS PHARMACEUTICALS is based in the United States.

Companies like INNOVUS PHARMACEUTICALS

In the same sector, and raised in the last eighteen months.

Abvc Biopharma$3.4M · Nov 2026Omni$244M · Nov 2026FibroBiologics$5.9M · Oct 2026Matchpoint Therapeutics$220M · Oct 2026Rx BandzOct 2026Hera Biotech$1.8M · Sept 2026

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app